HeartSciences Inc.
HSCS · NASDAQ
10/31/2025 | 7/31/2025 | 4/30/2025 | 1/31/2025 | |
|---|---|---|---|---|
| Valuation | ||||
| PEG Ratio | 0.02 | 0.03 | 0.02 | -0.02 |
| FCF Yield | -27,678.70% | -48.05% | -40.89% | -51.36% |
| EV / EBITDA | -3.63 | -1.75 | -3.08 | -1.54 |
| Quality | ||||
| ROIC | -40.99% | -36.83% | -60.19% | -49.68% |
| Gross Margin | -1,282.51% | 60.00% | -661.86% | 0.00% |
| Cash Conversion Ratio | 0.99 | 0.95 | 0.76 | 0.64 |
| Growth | ||||
| Revenue 3-Year CAGR | 14.01% | 47.44% | -5.47% | -100.00% |
| Free Cash Flow Growth | -120,016.61% | -22.25% | 2.28% | 25.29% |
| Safety | ||||
| Net Debt / EBITDA | 0.53 | 0.46 | -1.00 | -0.17 |
| Interest Coverage | -7.42 | -10.20 | -10.62 | -13.21 |
| Efficiency | ||||
| Inventory Turnover | 0.05 | 0.00 | 0.05 | 0.00 |
| Cash Conversion Cycle | 914.71 | 43,375.50 | 990.53 | 0.00 |